Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine
Reference24 articles.
1. Why are lopinavir and ritonavir effective against the newly emerged coronavirus 2019? Atomistic insights into the inhibitory mechanisms;Nutho;Biochemistry,2020
2. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan China: a descriptive study;Chen;Lancet,2020
3. Clinical features of patients infected with 2019 novel coronavirus in Wuhan China;Huang;Lancet,2020
4. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review;Sanders;JAMA,2020
5. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro;Choy;Antivir Res,2020
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. UiO-67 Metal–Organic Framework as Advanced Adsorbent for Antiviral Drugs from Water Environment;Catalysts;2024-08-29
2. Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 Mpro Main Protease Inhibitor through Intensive Virtual Screening and In Vitro Evaluation;International Journal of Molecular Sciences;2024-06-01
3. Favipiravir, remdesivir, and lopinavir: metabolites, degradation products and their analytical methods;Drug Metabolism Reviews;2024-03-06
4. The Design, Synthesis and Mechanism of Action of Paxlovid, a Protease Inhibitor Drug Combination for the Treatment of COVID-19;Pharmaceutics;2024-02-02
5. A Comprehensive Review of COVID-19-Infection- and Steroid-Treatment-Associated Bone Avascular Necrosis: A Multi-Study Analysis;Diagnostics;2024-01-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3